Successful treatment of sudden sensorineural hearing loss assures improvement of accompanying tinnitus

Rah, Yoon Chan; Park, Kyung T.; Yi, Yeo Jeen; Seok, Jungirl; Kang, Seong Il; Kim, Young H.

doi:10.1002/lary.25074

Cited by 23 publications

(30 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It was suggested that the hearing improvement may be a prognostic factor for tinnitus improvement, but the presence of tinnitus was not a prognostic factor for the recovery of hearing [25]. These findings are similar to those of the present study.…”

Section: Discussionsupporting

confidence: 90%

Intratympanic Drug Delivery for Tinnitus Treatment

Barreto¹,

Ledesma²,

Boger³

et al. 2017

Up to Date on Meniere's Disease

View full text Add to dashboard Cite

Objective: The aim of the study to evaluate the effectiveness of oral and injection intratympanic methylprednisolone to treat acute tinnitus associated with idiopathic sudden sensorineural hearing loss. Study design:Analytical, prospective and longitudinal study.Setting: Brasilia Institute of Otorhinolaryngology. Subjects and methods:Twenty-three subjects with acute tinnitus and idiopathic sudden sensorineural hearing loss, 13 treated with oral steroids only (Group 1) and 10 treated with methylprednisolone intratympanic injection as rescue therapy (Group 2), and evaluated by audiometry, otoacoustic emission, tinnitus handicap inventory (THI) and visual analog scale (VAS) to assess the degree of tinnitus annoyance, before treatment and after 3 months. Results:The annoyance due to tinnitus resulted in a mean VAS of 7.69 in the beginning of treatment and 5.15 3 months after treatment (Group 1), and 8.30 at the beginning and 6.00 3 months later (Group 2). In THI, average was 64.77 points at the beginning of treatment and 49.92 points 3 months later (Group 1) and 72.20 points at the beginning and 51.60 points after 3 months (Group 2). The results of audiometry and otoacoustic emissions showed significant improvement in both groups with significant differences intragroups before and after, but not between the groups. Conclusion:The results suggest that both oral and injection intratympanic methylprednisolone are effective treatment for acute tinnitus associated with idiopathic sudden sensorineural hearing loss in these patients.

show abstract

Section: Discussionsupporting

confidence: 90%

Intratympanic Drug Delivery for Tinnitus Treatment

Barreto¹,

Ledesma²,

Boger³

et al. 2017

Up to Date on Meniere's Disease

View full text Add to dashboard Cite

show abstract

“…Therefore, the effect of contralateral hearing may be limited to the development of acute tinnitus. Rah et al [2015] also reported that hearing recovery resulted in a decreased psychoemotional burden and improved tinnitus.…”

Section: Discussionmentioning

confidence: 99%

“…Even if hearing improves with treatment, tinnitus can persist. Patients with continuous tinnitus after hearing recovery may experience greater emotional distress than patients without tinnitus and reportedly have poorer outcomes [Chen et al, 2013;Rah et al, 2015].…”

Section: Introductionmentioning

confidence: 99%

Acute-Onset Tinnitus Is Associated with Contralateral Hearing in Sudden Deafness

et al. 2015

View full text Add to dashboard Cite

Objective: We aimed to evaluate the prognostic factors for acute-onset tinnitus associated with unilateral idiopathic sudden sensorineural hearing loss (ISSNHL) and to assess the relationship between these factors and the final recovery. Methods: A total of 770 patients with unilateral ISSNHL were enrolled retrospectively and their medical records reviewed. Patients were classified into two groups according to the presence of acute-onset tinnitus at the initial examination. Patient characteristics and the results of pure-tone audiometry were compared between the two groups initially and 3 months later. Results: A total of 70.9% (n = 546) of patients had tinnitus initially. There was no significant difference in the mean hearing thresholds of the affected ear irrespective of accompanying tinnitus. In contrast, patients with tinnitus in the affected ear tended to have significantly better mean hearing thresholds in the nonaffected ear (p < 0.05). The logistic regression analysis revealed that better mean hearing thresholds in the nonaffected ear were associated with tinnitus occurrence (p < 0.05). Better hearing thresholds in the nonaffected ear, younger age, absence of dizziness, low-tone hearing loss, and combined intratympanic dexamethasone injection were associated with full recovery (p < 0.05). However, tinnitus was not an independent risk factor for full recovery. Conclusion: Better contralateral hearing was associated with both an increased incidence of concurrent tinnitus and a better final recovery. However, tinnitus was not related to full recovery.

show abstract

“…From these results, they interpreted that tinnitus itself may not be a poor prognostic factor for hearing recovery but may be important for the repair of a damaged auditory system. Rah et al [22] reported that successful treatment of SSNHL may be an important factor in obtaining favorable long-term control of tinnitus accompanied by SSNHL. In this study, there were no significant differences in tinnitus, total THI, and THI subscales between the non-recovery and recovery groups.…”

Section: Discussionmentioning

confidence: 99%

Questionnaires in Patients with Unilateral Sudden Sensorineural Hearing Loss

Hwang

Joo²,

Song³

et al. 2017

Int Adv Otol

View full text Add to dashboard Cite

OBJECTIVE:In this study, we evaluated the prognostic value of the Dizziness Handicap Inventory (DHI) and the Tinnitus Handicap Inventory (THI) in patients with unilateral sudden sensorineural hearing loss (SSNHL). MATERIALS and METHODS:In total, 101 patients with unilateral SSNHL (44 women, 57 men), who were admitted and treated at our institution between December 2012 and June 2014, were included in the study. All patients completed the questionnaires for DHI and THI during their admission and were treated with bed rest and oral methylprednisolone (1 mg/kg, which was eventually tapered). Of these, 83 patients received intratympanic dexamethasone 4 times over a 2-week period. Demographic data, accompanying symptoms, and DHI and THI subscales were compared between the non-recovery group (Siegel's criteria type 4, n=63) and the recovery group (Siegel's criteria type 1-3, n=38). RESULTS:There were no significant differences between the two groups with regard to gender, hypertension, diabetes mellitus, cerebrovascular attack, and tinnitus. Patients in the non-recovery group were significantly older (51.53 vs. 50.24 years, p<0.05) and had a higher incidence of chronic kidney disease (10.53% vs. 1.59%, p<0.05) than those in the recovery group. Although more patients in the non-recovery group complained of dizziness (47.37% vs. 25.40%, p<0.05), DHI subscales were not significantly different between the groups. THI subscales were also not significantly different between the two groups.CONCLUSION: DHI and THI questionnaires may have limited prognostic value for patients with unilateral SSNHL.

show abstract

Successful treatment of sudden sensorineural hearing loss assures improvement of accompanying tinnitus

Abstract: 4.

Cited by 23 publications

References 24 publications

Intratympanic Drug Delivery for Tinnitus Treatment

Intratympanic Drug Delivery for Tinnitus Treatment

Acute-Onset Tinnitus Is Associated with Contralateral Hearing in Sudden Deafness

Questionnaires in Patients with Unilateral Sudden Sensorineural Hearing Loss

Contact Info

Product

Resources

About